Joana Katya Veras Rodrigues Sampaio Nunes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joana Katya Veras Rodrigues Sampaio Nunes has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Ana Maria Silva Lima
Universidade Ceuma
1 shared publication Anselmo Anderson Costa Sousa
Organizadores)
1 shared publication- Bianca Maranhão Vieira
Universidade Ceuma
1 shared publication - Carlos Gonzaga Melo Filho
Universidade Ceuma
1 shared publication - Catarina Gomes Chaves
Universidade Ceuma
1 shared publication - Darlan Ferreira da Silva
Universidade Ceuma
1 shared publication
Latest Publications
- Open Access
- 29 November 2022
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Medicina
- Vol. 101 (6)
Ansiedade e depressão em estudantes de medicina: estudo transversal
Introduction: The prevalence of depression and anxiety among university students is increasing in medical schools, and the female sex is indicated as a possible factor predisposing to mental exhaustion. In addition, the female sex is pointed out as a possible predisposing factor to mental exhaustion. The study aims to elucidate associated factors, as well as the prevalence of depressive and anxiety symptoms in medical students, to contribute to the establishment of prevention and treatment measures for future doctors. Methods: It was a cross-sectional study involving 812 medical students. A questionnaire on sociodemographic data, the Beck Depression Inventory - (BDI-II) and the Beck Anxiety Inventory - (BAI), were applied. Statistical analysis was performed using the SPSS 22 program. Normality was tested by the Shapiro-Wilk and correlations were evaluated by the Spearman correlation test. Results: A prevalence of 34.2% of depression was observed among students, considering mild, moderate, and severe symptoms. Regarding anxiety, our study observed a prevalence of 46.3%. Among the participants with anxiety, 56.4% had symptoms of depression: 22.6% were women; 50.3% of the students with depression had symptoms of anxiety, and 19.6% were women. After logistic regression analysis, symptoms of depression were related to anxiety (OR: 4.3; 95%CI: 2.6-6.8; p < 0.001) and female sex (OR: 1.7; 95%CI: 1.04-2.6; p = 0.0320). Anxiety symptoms, after logistic regression analysis, were associated with depression (OR: 4.3; 95%CI: 2.7-6.8; p < 0.001) and female sex (OR: 1.6; 95%CI: 1.04-2.4; p = 0.039). Conclusion: In this study, female students were more likely to develop anxiety and depression. However, further studies are needed to determine whether this phenomenon is due to female physiological mechanisms or social and cultural factors of patriarchal society.
- 29 November 2022
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Medicina
- Vol. 101 (6)
Open AccessAnsiedade e depressão em estudantes de medicina: estudo transversal
Introduction: The prevalence of depression and anxiety among university students is increasing in medical schools, and the female sex is indicated as a possible factor predisposing to mental exhaustion. In addition, the female sex is pointed out as a possible predisposing factor to mental exhaustion. The study aims to elucidate associated factors, as well as the prevalence of depressive and anxiety symptoms in medical students, to contribute to the establishment of prevention and treatment measures for future doctors. Methods: It was a cross-sectional study involving 812 medical students. A questionnaire on sociodemographic data, the Beck Depression Inventory - (BDI-II) and the Beck Anxiety Inventory - (BAI), were applied. Statistical analysis was performed using the SPSS 22 program. Normality was tested by the Shapiro-Wilk and correlations were evaluated by the Spearman correlation test. Results: A prevalence of 34.2% of depression was observed among students, considering mild, moderate, and severe symptoms. Regarding anxiety, our study observed a prevalence of 46.3%. Among the participants with anxiety, 56.4% had symptoms of depression: 22.6% were women; 50.3% of the students with depression had symptoms of anxiety, and 19.6% were women. After logistic regression analysis, symptoms of depression were related to anxiety (OR: 4.3; 95%CI: 2.6-6.8; p < 0.001) and female sex (OR: 1.7; 95%CI: 1.04-2.6; p = 0.0320). Anxiety symptoms, after logistic regression analysis, were associated with depression (OR: 4.3; 95%CI: 2.7-6.8; p < 0.001) and female sex (OR: 1.6; 95%CI: 1.04-2.4; p = 0.039). Conclusion: In this study, female students were more likely to develop anxiety and depression. However, further studies are needed to determine whether this phenomenon is due to female physiological mechanisms or social and cultural factors of patriarchal society.
- Open Access
- 21 July 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (10)
A eficácia dos tratamentos para a dor neuropática
The neuropathic pain is a type of chronic pain that arises from an injury or disease of the somatosensory nervous system, central or peripheral origin. It is a heterogeneous range of pain syndromes, with different pathophysiological mechanisms and different degrees of intensity of signs and symptoms. As a result, there are several therapeutic resources, whether they are pharmacological, physical or cognitive, and obstacles to an adequate and effective treatment. From the advances in therapy alone, only a minority of patients achieve significant pain relief. To analyze available treatments for neuropathic pain and present the best pharmacological options. A literature review was carried out, using the descriptors "pain", "neuropathy", "treatment". The database used was PUBMED, with filters for full free text, systematic review and meta-analysis, from 2016 to 2021. This review found that there is evident efficacy when using gabapentin and pregabalin to relieve neuropathic pain. These drugs are neuromodulators of the antidepressant class, and both showed greater improvement than the placebo group. In addition, the use of vitamin B12 (methylcobalamin) and acupuncture was also shown to be effective, but on a smaller scale and with a longer treatment time. Studies on the treatment of neuropathic pain have increased over the years, which allows us to think about significant advances in the future. Currently, drugs such as Pregabalin and Gabapentin are used, or non-pharmacological methods such as acupuncture. Therefore, greater attention should be given to studies on treatments for this disease, aiming at the patient's well-being.
- 21 July 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (10)
Open AccessA eficácia dos tratamentos para a dor neuropática
The neuropathic pain is a type of chronic pain that arises from an injury or disease of the somatosensory nervous system, central or peripheral origin. It is a heterogeneous range of pain syndromes, with different pathophysiological mechanisms and different degrees of intensity of signs and symptoms. As a result, there are several therapeutic resources, whether they are pharmacological, physical or cognitive, and obstacles to an adequate and effective treatment. From the advances in therapy alone, only a minority of patients achieve significant pain relief. To analyze available treatments for neuropathic pain and present the best pharmacological options. A literature review was carried out, using the descriptors "pain", "neuropathy", "treatment". The database used was PUBMED, with filters for full free text, systematic review and meta-analysis, from 2016 to 2021. This review found that there is evident efficacy when using gabapentin and pregabalin to relieve neuropathic pain. These drugs are neuromodulators of the antidepressant class, and both showed greater improvement than the placebo group. In addition, the use of vitamin B12 (methylcobalamin) and acupuncture was also shown to be effective, but on a smaller scale and with a longer treatment time. Studies on the treatment of neuropathic pain have increased over the years, which allows us to think about significant advances in the future. Currently, drugs such as Pregabalin and Gabapentin are used, or non-pharmacological methods such as acupuncture. Therefore, greater attention should be given to studies on treatments for this disease, aiming at the patient's well-being.
- Open Access
- 1 January 2022
- Published by Even3
AS IMPLICAÇÕES DA MORTE E DO LUTO DO CÔNJUGE NA SAÚDE MENTAL DA PESSOA IDOSA
- 1 January 2022
- Published by Even3
Open AccessAS IMPLICAÇÕES DA MORTE E DO LUTO DO CÔNJUGE NA SAÚDE MENTAL DA PESSOA IDOSA